Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
Abroad (travel likely)Recruiting
Conditions
Hereditary Transthyretin-mediated (hATTR) Amyloidosis · Polyneuropathy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Clinical Trial Site, Iowa City, Iowa, United States
Clinical Trial Site, Nantes, France
Clinical Trial Site, Münster, Germany
Clinical Trial Site, Pavia, Italy
Clinical Trial Site, Groningen, Netherlands
Clinical Trial Site, Lisbon, Portugal
Clinical Trial Site, Madrid, Spain
Study leads
Medical Director
Study Director
Alnylam Pharmaceuticals